SWKH News Alert Swk Hldgs Corp (SWKH) 1.4500 09/28/2014 00:1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Swk Hldgs Corp (SWKH) 1.4500 $SWKH

SWK Holdings Corporation Announces Up to Approximately $115 Million Equity Financing
GlobeNewswire - Mon Aug 18, 4:55PM CDT
SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company" , a life science focused specialty finance company, announced that on August 18, 2014 that it has entered into a Securities Purchase Agreement (the "Purchase Agreement" and related documents with Carlson Capital, L.P. and affiliates ("Carlson" whereby in a series of transactions funds affiliated with Carlson (the "Stockholder" will purchase new shares in the Company such that its ownership increases to 69.0%.

Response Genetics reports launch of USD12.0m credit facility
M2 - Wed Aug 06, 6:29AM CDT
Molecular diagnostic company Response Genetics (NasdaqCM:RGDX) reported on Tuesday the execution of up to USD12.0m credit agreement with SWK Funding (SWK), a wholly-owned subsidiary of SWK Holdings ( agent).

Response Genetics Secures $12.0 Million Credit Facility
GlobeNewswire - Tue Aug 05, 6:08AM CDT
Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, and SWK Funding LLC ("SWK" , a wholly-owned subsidiary of SWK Holdings Corporation, as the agent, entered into a credit agreement (the "Credit Agreement" pursuant to which the lenders party thereto provide Response Genetics (the "Company" a term loan in the principal amount up to $12.0 million (the "Loan" .

SWK Holdings Corporation Special Committee Responds to Carlson Capital Letter
GlobeNewswire - Mon Jun 23, 10:02AM CDT
The Special Committee of SWK Holdings Corporation (OTCBB:SWKH) ("SWK" or the "Company" , a life science focused specialty finance company, today issued the following statement regarding Carlson Capital's letter to the Special Committee dated June 20, 2014:

SWK Holdings Corporation Announces 2013 Fourth Quarter and Full-Year Financial Results
GlobeNewswire - Mon Mar 31, 9:27AM CDT
-- Net income and adjusted net income to SWK stockholders of $12.9 million, or $0.31 per share, and $3.0 million, or $0.07 per share, respectively, for fiscal year 2013 vs. a loss of $1.4 million, or $(0.03) per share, for 2012

InSite Vision receives USD1m in royalties from the sale of Besivance
M2 - Wed Feb 05, 4:47AM CST
US-based ophthalmologic company InSite Vision Incorporated (Other OTC:INSV) stated on Tuesday that Besivance 2013 net sales has generated an additional USD1m milestone payment.

InSite Vision Announces Achievement of the $1 Million Milestone From the Sale of Besivance(R) Royalty
Business Wire - Tue Feb 04, 7:30AM CST
InSite Vision Incorporated (OTCBB: INSV) today announced that Besivance 2013 net sales achieved the levels necessary to earn InSite Vision an additional $1 million milestone payment from the Besivance royalty purchasers, SWK Funding LLC, a wholly-owned subsidiary of SWK Holdings Corporation (OTCBB: SWKH), and Bess Royalty, L.P. The $16 million total cash consideration to InSite Vision included a $15 million upfront payment in April, 2013, and a $1 million milestone payment which will be paid this month. Besivance (besifloxacin ophthalmic suspension) 0.6% is marketed globally by Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, for the treatment of bacterial conjunctivitis.

Parnell Accelerates Expansion Plans
PR Newswire - Mon Feb 03, 3:22PM CST
Parnell, Inc. has announced further expansion plans of its North American operations based in Overland Park, Kansas. Robert Joseph President & CEO said; "This week we completed a $25m debt refinancing with SWK Holdings, Corporation based in Dallas, Texas. This capital transaction will ensure the continued expansion of our dairy franchise and fund our varied pipeline across companion animal and production animal products". "SWK is very pleased to partner with Parnell to support the build out of the company's animal health franchise with non-dilutive capital," said Brett Pope, CEO of SWK Holdings Corporation. "The combination of the company's innovative dairy hormone business, excellent management team and global distribution provide a compelling platform for future value creation."

SWK Holdings Corporation Announces Closing of an Up to $30 Million Debt Financing
GlobeNewswire - Mon Sep 09, 7:00AM CDT
SWK Holdings Corporation (OTCQB:SWKH) ("SWK" or the "Company" , a life science focused specialty finance company, announced today that it has closed a credit facility of up to $30 million from a fund affiliated with Carlson Capital, L.P. ("Carlson" . The credit facility has a four-year term and provides financing against all of SWK's assets. In conjunction with the credit facility, SWK's Board of Directors has agreed to waive certain "NOL pill" provisions to allow Carlson to increase its ownership of the Company. Carlson has been SWK's largest shareholder since the fourth quarter of 2009 and currently owns approximately 28% of the Company's outstanding stock.

CRWESELECT Daily Stock Watch MVC Capital, Inc. (NYSE:MVC), Crown Equity Holdings Inc. (OTCQB:CRWE), and SWK Holdings Corporation (OTCQB:SWKH)
WorldStockWire - Fri Aug 09, 11:45AM CDT
CRWEselect.com, a division of Crown Equity Holdings Inc. (OTCQB:CRWE) tracks stocks daily and is pleased to offer its hot stock to watch . Our stock focus today is on:

SWK Holdings Corporation Announces the 2013 Annual Shareholders Meeting Will Be Held on September 18, 2013
GlobeNewswire - Thu Aug 01, 11:29AM CDT
SWK Holdings Corporation ("SWK" or the "Company" (SWKH:OB) today announced that it has set Wednesday, September 18, 2013, as the date of its 2013 Annual Meeting of Stockholders (the "Annual Meeting" , and that the record date for determining stockholders entitled to vote at the Annual Meeting is Friday, August 16, 2013. The meeting will be held in Dallas, Texas. The deadline for stockholders to timely submit to the Company proposals to be brought before the Annual Meeting pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended, is Monday, August 12, 2013. Pursuant to the Company's Bylaws, the deadline for stockholders to timely submit proposals to be brought before the Annual Meeting (except for proposals pursuant to Rule 14a-8) and to nominate candidates for the Board of Directors is Monday, August 12, 2013.

InSite Vision Incorporated reports sale of Besivance royalty for up to USD16m
M2 - Wed Apr 03, 6:32AM CDT
Ophthalmologic company InSite Vision Incorporated (OTC Markets:INSV) said on Tuesday that it has agreed to sell its royalty on future sales of Besivance for up to USD16m.

InSite Vision Announces Sale of Besivance(R) Royalty for $15 Million Plus a $1 Million Potential Milestone in Early 2014
Business Wire - Tue Apr 02, 7:30AM CDT
InSite Vision Incorporated (OTCBB: INSV) today announced that it agreed to sell its royalty on future sales of Besivance(R), to SWK Funding LLC, a wholly-owned subsidiary of SWK Holdings Corporation (OTCBB: SWKH) and Bess Royalty, L.P. for up to $16 million. Besivance (besifloxacin ophthalmic suspension) 0.6% is marketed globally by Bausch + Lomb for the treatment of bacterial conjunctivitis.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 74

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Australia Leads TTW's 2027 Global Travel Country List

Updated Category News Views 66

A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...

Continue Reading
EyePoint Lawsuit Puts DURAVYU Claims Under a Microscope

Updated Category News Views 107

Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 407

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 181

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 83

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 481

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 473

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 689

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 744

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading

Top 5 Most Recently Viewed Articles

Rising Trends in the Office Sleep Pod Market: A Growth Story

Updated Category News Views 187

Overview of the Office Sleep Pod Market The Office Sleep Pod Market is witnessing a remarkable surge, driven by a confluence of factors centered around workplace wellness, the link between rest and employee productivity, and the incorporation of modern workplace infrastructure by global companies. The appetite for sleep pods is being fueled by stress-laden corporate...

Continue Reading
Ancient Crunch Expands into Whole Foods' 400 Stores

Updated Category News Views 28

The Move into Whole Foods: A Strategic Leap If you'd told me years ago that a snack made with beef tallow would make waves in the premium grocery market, I'd have laughed in your face. But here we are—Ancient Crunch is making a bold power play into Whole Foods Market, placing their sons of grit and gusto, MASA and Vandy, onto 400 new shelves nationwide. It's like...

Continue Reading
Acuity Brands Unveils Comprehensive Environmental Report 2024

Updated Category News Views 294

Acuity Brands Reveals its EarthLIGHT Report for 2024 ATLANTA, Dec. 10, 2024 - Acuity Brands, Inc. (NYSE: AYI), a leading industrial technology company, has published its annual EarthLIGHT Report. This document outlines significant accomplishments in Environmental, Social, and Governance (ESG) for the fiscal year 2024, while also providing insights into key strategic...

Continue Reading
RAPT Therapeutics Announces Participation in Investor Conferences

Updated Category News Views 138

RAPT Therapeutics to Engage Investors in Upcoming Conferences RAPT Therapeutics, Inc. (NASDAQ: RAPT), an innovative biopharmaceutical company based in South San Francisco, is gearing up for a series of influential investor conferences this March. The company's focus on developing cutting-edge therapies for immunological conditions positions them at the forefront of...

Continue Reading
Opus One Gold Completes Final Tranche of Private Placement Funding

Updated Category News Views 66

Opus One Gold Completes Final Tranche of Private Placement Funding Opus One Gold Corporation (OOR: TSXV) has achieved a significant milestone by wrapping up the second tranche of its private placement. This non-brokered offering has successfully drawn in substantial investment, reflecting strong market confidence in Opus One’s potential. Details of the Offering In this...

Continue Reading